Israel News App

Hematocrit, Phlebotomy Benefits Seen With Rusfertide in PV – Medscape

Written by

admin

in

  1. Hematocrit, Phlebotomy Benefits Seen With Rusfertide in PV  Medscape
  2. 52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV  AJMC
  3. Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response…

Continue Reading